Healius

Healius Limited is an Australian health services company headquartered in St Leonards, New South Wales, Australia. Founded in 1994 as Primary Health Care Limited, it is the country's second-largest pathology provider and third-largest diagnostic imaging provider, with the imaging business set for sale in early 2025. The company's primary segments lude Pathology (75% of revenue: lab testing and diagnostics) and Diagnostic Imaging (25%: MRI, CT, and ultrasound services). Healius operates 2,335 sites across Australia, luding 2,185 pathology labs, 135 imaging centers, and 15 day hospitals, serving public health Medicare and private clients with 8,963 employees. Its supply chain involves third-party equipment and reagent suppliers, with TPRM per the 2024 Annual Report emphasizing ESG audits, data privacy under the Australian Privacy Priples (similar to GDPR), and supply chain transparency for ethical sourcing and net-zero by 2030. The company invests in digital pathology and AI diagnostics. In FY 2024, ending June 30, Healius reported revenues of A$1.344 billion ($900 million), up 6% from 2023, with EBITDA of A$250 million, driven by 75% pathology revenue growth amid post-COVID recovery.